Smith Darren Charltoninsider trades
In SEC Form 4 filings, Smith Darren Charlton is listed as Group Chief Financial Officer of Telix Pharmaceuticals Ltd (TLX). In the last 90 days, Smith Darren Charlton bought $20K of Telix Pharmaceuticals Ltd (TLX) on the open market and sold none. The purchase was $20K of Telix Pharmaceuticals Ltd (TLX) on Sep 7.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TLXTelix Pharmaceuticals Ltd | Group Chief Financial Officer | 1 | Sep 14 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-14
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.